Drugmakers Argue Federal Law Preempts Incretin Suits

, The National Law Journal

   | 0 Comments

Federal law preempts the claims plaintiffs are making that incretin-based drugs caused their pancreatic cancer, a group of drugmakers argued in their latest court filing on the issue. The defendants say there is no clear evidence the U.S. Food and Drug Administration would have changed the warnings given on the risks of those drugs.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202657299509

Thank you!

This article's comments will be reviewed.